| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |